Fig. 7From: Impact of ITPA gene polymorphism for predicting anemia and treatment outcome in HCV infected patients taking Sofosbuvir Ribavirin therapyRibavirin dose reduction on basis of ITPA genotype (Kaplan-mere curve). (A) Ribavirin reduction in rs1127354-CC & CA genotype. (B) Ribavirin dose reduction in ITPA rs7270101 AA and AC genotypeBack to article page